Advanced Digital Pathology Solutions at PreciPoint
Comprehensive solutions for digitizing pathology workflows, and enhancing cancer diagnostics, research, and education.
Comprehensive solutions for digitizing pathology workflows, and enhancing cancer diagnostics, research, and education.
Advanced Digital Pathology Solutions at PreciPoint
Slogan: Comprehensive solutions for digitizing pathology workflows, and enhancing cancer diagnostics, research, and education.
PreciPoint, a Germany-based ISO 13485:2016-certified leading international solutions provider for digitizing and automating pathology laboratories, is dedicated to innovation, precision, and quality. The company offers a range of solutions, including advanced microscope systems, automated test systems, and customized software for image management and analysis. Founded in 2018, PreciPoint's flagship product, the iO:M8, is particularly valuable for intraoperative viewing of frozen sections during surgical procedures.
The company's last investment was a €4.50M Series A investment on 06 June 2023. PreciPoint operates within the Health Care, Industrial, and Medical Devices industries from their headquarters in Germany. With a strong focus on advancing the field of pathology, PreciPoint continues to deliver state-of-the-art solutions for pathology laboratories, positioning itself as a forward-thinking brand committed to enhancing efficiency and accuracy in digital pathology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | €4.50M | - | 06 Jun 2023 | |
| Series A | €10.00M | 1 | bm-t beteiligungsmanagement thuringen | 27 Jul 2022 |
| Seed Round | €2.00M | 1 |
|
22 May 2018 |
| Pre Seed Round | €340.00K | - | 01 Nov 2017 | |
| Pre Seed Round | €150.00K | - | 12 Jul 2016 |
No recent news or press coverage available for Advanced Digital Pathology Solutions at PreciPoint.
We care about your data, and we'd love to use cookies make your experience better.
